Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure clinical trial (NCT06300177). Contact the study team or your healthcare provider for specific answers.

Question 2

How does D-1553 compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure clinical trial (NCT06300177). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from D-1553 and docetaxel?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure clinical trial (NCT06300177). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure clinical trial (NCT06300177). Contact the study team or your healthcare provider for specific answers.

Question 5

What tests will be done to monitor my condition during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure clinical trial (NCT06300177). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or my cancer progresses while in the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure clinical trial (NCT06300177). Contact the study team or your healthcare provider for specific answers.

What this study is about